Cromos Pharma making sure your clinical trial is feasible
It is estimated that up to 80% of clinical studies fail to recruit sufficient numbers of participants. These failures waste valuable resources and time as well as delaying new treatments reaching patients. At Cromos Pharma we understand how important it is to conduct robust feasibility assessments of clinical trials to optimize the chances of success. That’s why we have developed our Free Feasibility Reports initiative to assist sponsors considering expanding their clinical trials into Central and Eastern Europe.
FREE FEASIBILITY REPORT
- An assessment of the competitive landscape
- Review of local standards of care
- Historical recruitment statistics
- Regulatory requirements and timelines
- Realistic recruitment projections
HOW IT WORKS?
NO PATIENTS – NO PAYMENT
The accuracy of our feasibility reports is backed by our unrivalled record for patient recruitment – our team has met or reduced enrolment timelines in 95% of trials conducted. Responsible recruitment is supported by our proprietary “No Patients – No Payment” risk sharing program through which we give our assurance that your enrollment goals, budgets, and timelines will be met. Simply put, if we don’t recruit – you don’t pay.
About Cromos Pharma
Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range of therapeutic indications. Our expert team, comprised of 95% MDs, has extensive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management.
Cromos Pharma has experience in delivering success in a wide range of trial types, from biosimilars and generics, to successfully managing trials of novel therapeutics in a wide range of clinical indications. Our team provides full-service solutions to international pharma and biotech companies in high-recruiting regions, assuring exceptional data quality. Cromos Pharma combines global expertise with in-depth experience and knowledge in the US, Central and Eastern Europe, Central Asia, Republic of Georgia, and Turkey to offer exceptional patient recruitment. Our team has met or reduced enrollment timelines in 95% of conducted trials.
We provide accelerated study start-up timelines in our regions of operation. Regulatory inspections by FDA and EMA and site audits attest to the highest quality of our clinical data.
Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is located in Portland, Oregon, USA and its European HQ is in Dublin, Ireland.